Area of research
Radiology, Nuclear Medicine and Imaging · Biomedical Engineering
Research interest
Research interests include Medical Imaging Techniques and Applications, Radiopharmaceutical Chemistry and Applications, Radiomics and Machine Learning in Medical Imaging, and Advanced X-ray and CT Imaging.
Lutetium-177–PSMA-617 or cabazitaxel in metastatic prostate cancer: circulating tumor DNA analysis of the randomized phase 2 TheraP trial
Consensus Nomenclature for Radionuclide Therapy: Initial Recommendations from Nuclear Medicine Global Initiative
ARTnet Perspectives and Contributions to Theranostics.
Theranostic Radioembolization: Radiation Dosimetry-Guided Treatment Planning and Delivery.
A retrospective comparison of [<sup>18</sup>F]FDG radiation dose following a transition from conventional to long axial field of view PET/CT.
Biomarkers to Inform Prognosis and Treatment for Unresectable or Metastatic GEP-NENs
Evolving SPECT-CT technology.
Letter to the Editor: FDG Liver Biodistribution.
Overall survival with [177Lu]Lu-PSMA-617 versus cabazitaxel in metastatic castration-resistant prostate cancer (TheraP): secondary outcomes of a randomised, open-label, phase 2 trial
Partial volume effect in SPECT & PET imaging and impact on radionuclide dosimetry estimates.
[<sup>18</sup>F]-fluoroethyl-L-tyrosine (FET) in glioblastoma (FIG) TROG 18.06 study: protocol for a prospective, multicentre PET/CT trial.
Single-centre experience with peptide receptor radionuclide therapy for neuroendocrine tumours (NETs): results using a theranostic molecular imaging-guided approach.
Dual [68Ga]DOTATATE and [18F]FDG PET/CT in patients with metastatic gastroenteropancreatic neuroendocrine neoplasms: a multicentre validation of the NETPET score
<sup>64</sup>Cu Treatment Planning and<sup>67</sup>Cu Therapy with Radiolabeled [<sup>64</sup>Cu/<sup>67</sup>Cu]MeCOSar-Octreotate in Subjects with Unresectable Multifocal Meningioma: Initial Results for Human Imaging, Safety, Biodistribution, and Radiation Dosimetry
Towards personalised dosimetry in patients with liver malignancy treated with <sup>90</sup>Y-SIRT using in vivo-driven radiobiological parameters.
Practical learning through radiation physics problem solving
AN UNUSUAL CAUSE OF GAMMA CAMERA CONTAMINATION.
Letter to Editor Re: “Combined Quantification of 18F-FDG and 68Ga-DOTATATE PET/CT for Prognosis in High-Grade Gastroenteropancreatic Neuroendocrine Neoplasms” (https://doi.org/10.1016/j.acra.2021.10.004)
Theranostic SPECT reconstruction for improved resolution: application to radionuclide therapy dosimetry.
Quantitative PET in the 2020s: a roadmap
Quantifying the effects of absorbed dose from radioembolisation on healthy liver function with [<sup>99m</sup>Tc]TcMebrofenin.
The future of radiotherapy is molecular
RetroSPECT: Gallium-67 As A Theranostic Imaging Agent
Diagnostic Accuracy of Positron Emission Tomography/Computed Tomography of the Head, Neck, and Chest for Giant Cell Arteritis: A Prospective, Double‐Blind, Cross‐Sectional Study
Performance evaluation of quantitative SPECT/CT using NEMA NU 2 PET methodology.
Follow-up Recommendations for Completely Resected Gastroenteropancreatic Neuroendocrine Tumors
Feasibility and accuracy of single time point imaging for renal dosimetry following 177Lu-DOTATATE (‘Lutate’) therapy
Accuracy of Dose Calibrators for <sup>68</sup>Ga PET Imaging: Unexpected Findings in a Multicenter Clinical Pretrial Assessment
Safety and activity of microRNA-loaded minicells in patients with recurrent malignant pleural mesothelioma: a first-in-man, phase 1, open-label, dose-escalation study
Dual Somatostatin Receptor/FDG PET/CT Imaging in Metastatic Neuroendocrine Tumours: Proposal for a Novel Grading Scheme with Prognostic Significance